Loading…
Based on limited metadata, this FDA Warning Letter was issued to The GBS dba Alpha Arogya India Pvt Ltd on April 13, 2020, regarding drug products. Without access to the full warning letter text or subject line, the specific regulatory violations cannot be determined from the available information. The letter falls under FDA's drug product oversight, though the particular issuing office and violation details remain unavailable in this metadata record.